Paul Prikazsky’s Post

In an online survey conducted by U.S. News & World Report, results showed that patient experience and satisfaction is one of the key characteristics individuals consider when choosing an ambulatory surgery center (ASC). https://lnkd.in/eTj62Agm

From musculoskeletal surgeries like spinal fusions to cardiovascular procedures like stent placements, employers' surgical care costs can spiral out of control, consuming a significant chunk of a company’s healthcare budget. In this post, we provide three strategies for curtailing surgical care spend while still ensuring access to high-quality care: https://lnkd.in/eY2Ejp5B #carrumhealth #valuebasedcare #coe #surgery

The Cost-Effectiveness of Early High-Acuity Postoperative Care for Medium-Risk Surgical Patients https://lnkd.in/gqr4TaiV #anesthesia #cost #effectiveness #care #risk #surgical #surgery #patients

The global Ambulatory Surgery market was valued at US$ 304240 million in 2023 and is anticipated to reach US$ 478410 million by 2030 witnessing a CAGR of 6.6% during the forecast period 20242030. #GlobalAmbulatorySurgeryMarket #OutpatientSurgery #HealthcareTrends #MedicalAdvancements #CostEffectiveHealthcare #MinimallyInvasiveSurgery #GastrointestinalSurgery #CardiovascularSurgery #NeurologicalSurgery #OrthopedicSurgery

When planning inpatient and outpatient surgeries in the same operating room blocks, uncertainty and patient needs vary depending on their type. For instance, while inpatients have a higher variability in the surgery duration due to the average more complex procedures, outpatients register a higher rate of late cancellations or no-shows. We address this problem with a stochastic optimization approach in our new open-access paper "Multi-objective stochastic scheduling of inpatient and outpatient surgeries" on Flexible Services and Manufacturing journal. A joint work with Ambrogio Maria Bernardelli and Lorenzo Bonasera (Università degli Studi di Pavia), and Eleonora Vercesi (USI Università della Svizzera italiana). https://lnkd.in/dKUUgpmd

🔬 Exploring Patient Acceptance of Bilateral Cataract Surgery Before and During COVID-19 🔬 A study led by Vishal Shah, Khayam Naderi, Laura Maubon, Ashmal Jameel, Darshak Patel, Jack Gormley, sanjeev heemraz, AZAN ELODIE, Seema Verma, Sancy Low, David Obrart from the National Health Service (NHS) provides insightful findings into patient acceptance of immediate sequential bilateral cataract surgery (ISBCS). 👁️ The study found that 45% of participants were open to undergoing ISBCS, appreciating the convenience and reduced need for multiple hospital visits. However, concerns about simultaneous bilateral complications were significant, with 50% of patients expressing worries. 🦠 During the lockdown, changes in attitudes were noted, particularly regarding the urgency to minimize time off work and tolerance for prolonged hospital visits. 📊 These insights are crucial for healthcare providers as they indicate a need for enhanced patient education about ISBCS to alleviate fears and improve familiarity with the procedure. 📘 Dive deeper into this study and earn 1.0 CME by learning about the evolving patient perspectives in cataract surgery during unprecedented times. https://lnkd.in/dvKzegQR #Ophthalmology #CataractSurgery #PatientCare #COVID19 #HealthcareResearch #CME #MedicalEducation

As the number of procedures being performed at ambulatory surgery centers (ASCs) increases, the importance of patient-safety processes increases as well. From the time a patient is admitted until they’re discharged, labels can play an essential role in reducing preventable errors. Read more about the 10 types of labels that can complement patient-care processes in an ASC — and how they can help caregivers identify, verify, and communicate information that minimizes patient risk: https://bit.ly/3zkec1r Reach out to me with any questions on how RRD's label team can help your helathcare facility minimize patient risk. #RRD #UAL #UALlabels #labels #healthcare #patientcare #patientsafety #ambulatorysurgerycenters

Parkview Health and Surgery Partners (NASDAQ: SGRY) today announced a collaborative agreement that will grow ambulatory surgical center (ASC) joint ventures across the state of Indiana. The collaboration aims to serve communities by improving access to high-quality, affordable and patient-centered surgical care in partnership with independent physician groups. “As the health care provider of choice in northeast Indiana, Parkview Health is excited to expand surgical care throughout the state,” said Dr. Roy Robertson, president, Parkview Heart Institute and specialty service lines. “This partnership will allow us to serve more Indiana communities with convenient, high-quality care, while also reducing their healthcare costs. By combining the expertise and experience of both organizations, Parkview can continue to strengthen its commitment to increasing access to care.” “At Surgery Partners, our mission is to enhance patient quality of life through partnership,” said Marissa Brittenham, Chief Strategy Officer, Surgery Partners. “We are pleased to enter the Indiana market with our trusted partners at Parkview. Our organizations together combine clinical operations excellence, deep local market expertise and relationships, and industry-leading surgical facility management.” ASCs are standalone facilities that provide outpatient surgery separate from an acute care hospital. ASCs often have lower overhead costs, which can help reduce costs for employers and patients. Parkview has existing ASCs in northeast Indiana where the healthcare system is based. The new collaborative model will work with physicians to build and acquire ASCs with a focus on increasing access outside of Parkview’s core service area. “Partnering with physicians is key to our ability to offer the highest quality care,” said Dr. Alan McGee, president, Parkview Health Orthopedics and orthopedic service line. “As a physician-led organization, Parkview values the unique perspectives and expertise physicians bring to the table.” This partnership will not only enhance the patient experience but also cultivate relationships with top surgeons in Indiana. Surgeons will have the opportunity to further invest in their practice, patients, and local community, and benefit from expert support services while retaining their independence and flexibility. #surgery #partnership #healthcarenews

As the number of procedures being performed at ambulatory surgery centers (ASCs) increases, the importance of patient-safety processes increases as well. From the time a patient is admitted until they’re discharged, labels can play an essential role in reducing preventable errors. Read more about the 10 types of labels that can complement patient-care processes in an ASC — and how they can help caregivers identify, verify, and communicate information that minimizes patient risk: https://bit.ly/3zkec1r #RRD #UAL #UALlabels #labels #healthcare #patientcare #patientsafety #ambulatorysurgerycenters

The relationship between MSK-focused digital health companies (DHC) and Orthopedic Surgeons is a complicated one. To this point, it could be argued it has been more adversarial than collaborative. Both sides want the same thing: high-quality, evidence-based treatment that's cost-effective, timely, and accessible. Pretty simple, right? In reality, the situation isn't quite so straightforward. To DHCs, Orthopaedic Surgeons are viewed as purveyors of low value, unnecessary care, incentivized by the FFS to favor lucrative procedures over less costly, less invasive, and equally effective treatments. Their core value proposition has been to reduce MSK spend by keeping patients/employees away from knife-happy bone docs. To Orthopaedic Surgeons, DHCs are unwelcome gatekeepers themselves incentivized to push less costly but potentially inappropriate care that delays definitive treatment. To Orthopods, DHCs don't know what they don't know and aren't equipped for when patients' needs outstrip their capabilities. Though there is some truth in these assessments, can the sides ever find common ground? How can each side provide value to the other? Patients benefit from the multi-disciplinary, holistic approach and ease of access provided by DHCs. Orthopods benefit when lower acuity problems or appropriate conservative treatment by DHCs. On the other side, DHCs benefit by having Orthopods as a vetted resource for higher acuity, more complex problems and by establishing networks of high value specialists. As CMS, self-insured employers, and direct contractors seek out alternative models, DHCs and Orthopedic Surgeons can work together in risk-sharing models to achieve VBC MSK goals for the benefit of all. Pressure is mounting on both sides. Unicorn (or once-unicorn) MSK DHCs are being pushed by investors to find an exit. Going public will lay bare the effectiveness of both their clinical and business model. The guess here is that lack of integration with traditional, brick-and-mortar care and inability to drive ROI and growth beyond procedure avoidance will be a hinderance --full spectrum treatment a differentiator. Orthopods are facing a future driven by accountable care, mandatory participation in VBC models, and condition-specific episodes of care. Inability to adapt or provide the services needed to thrive in these models risks obsolescence. Partnering with DHCs can help Orthopedic Surgeons more effectively navigate the requirements of a more integrated approach (including health coaching, virtual PT, RPM/RTM, PROMS, etc.). Will the sides cross the aisle and embrace collaboration? Or do both still believe they can go it alone? Is the door opening or closing? #medicine #health #healthcare #healthtech #healthcaretechnology #digitalhealth #msk #healthcareinnovation